| P2093 | author name string | Jean-Philippe Bouchara | |
| | Rachid Zouhair | |
| | Sandrine Giraud | |
| | Bienvenue Razafimandimby | |
| | Amandine Rougeron | |
| | Abdessamad Kobi | |
| P2860 | cites work | Multiple factor analysis (AFMULT package) | Q56763806 |
| | Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection | Q57254163 |
| | MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods | Q27860929 |
| | Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening | Q28217255 |
| | Molecular Phylogeny of the Pseudallescheria boydii Species Complex: Proposal of Two New Species | Q28315329 |
| | Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii | Q31139988 |
| | Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environments and their distribution in clinical samples | Q33393265 |
| | Geosmithia argillacea: an emerging pathogen in patients with cystic fibrosis. | Q33963545 |
| | Isolation of the fungus Geosmithia argillacea in sputum of people with cystic fibrosis | Q33963639 |
| | Rasamsonia, a new genus comprising thermotolerant and thermophilic Talaromyces and Geosmithia species | Q34037375 |
| | Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis | Q34196570 |
| | Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review | Q34910464 |
| | Genotyping of Scedosporium species: a review of molecular approaches | Q37351703 |
| | Infection prevention and control in cystic fibrosis | Q37872183 |
| | Antifungal susceptibilities of the species of the Pseudallescheria boydii complex | Q40903665 |
| | Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. | Q42110667 |
| | Identification of Pseudallescheria and Scedosporium species by three molecular methods. | Q42706961 |
| | Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis | Q45144771 |
| | Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome | Q45198277 |
| | Cystic fibrosis mortality trends in France. | Q50787419 |
| | The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. | Q51134002 |
| P433 | issue | 6 | |
| P921 | main subject | cystic fibrosis | Q178194 |
| | Pseudallescheria boydii | Q7254196 |
| | Scedosporium apiospermum | Q54371054 |
| P304 | page(s) | 603-613 | |
| P577 | publication date | 2013-03-05 | |
| P1433 | published in | Medical Mycology | Q6806389 |
| P1476 | title | Distribution of the different species of the Pseudallescheria boydii/Scedosporium apiospermum complex in French patients with cystic fibrosis | |
| P478 | volume | 51 | |